spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Pharma and Device Packaging and Labelling West Coast 2018

27-28 November 2018
Burlingame, CA

The second edition of the Pharma and Device Packaging and Labeling West Coast was a thought-provoking two days of engaging presentations, discussion and networking.

Chaired by Ms Tennyson Hicks, Associate Program Director at Genentech, the event focused on how to streamline collaboration between packaging and labelling departments, best practices for the best packaging materials and perfect timelines for labelling.

Speakers and delegates representing all of the most important companies in the areas, such as Allergan, Amgen, BioMarin, Genentech participated in an event which saw a fantastic opportunity to have a really insightful view on the challenges faced by different teams within the same company, so that the entry into the market can happen as quickly and successfully as possible.

Following on from this success, Arena International is pleased to announce that this unique event will be returning once again in 2018.

The 2018 program aims to stay abreast of the latest industry trends and operational challenges in the commercial side for biopharma and medical devices companies. If you have an interesting topic proposal, please get in touch with the program director.

 
Print this page
Send to a friend
   
Banner of Bio Trinity_Events_Page on Samedan
spacer
Industry Events

14th Annual Biomarkers Congress

21-22 February 2019, Manchester Central Convention Complex, UK

Oxford Global is proud to present for the 14th year our flagship Biomarkers Congress, taking place 21 – 22 February 2019 in Manchester, UK. An updated programme ensures you will benefit from talks on the latest strategies and technologies impacting growth in the biomarker industry.
More info >>

White Papers

Characterisation of Biopharmaceutical Proteins

Reading Scientific Services Ltd (RSSL)

Over the next five years it is anticipated that there is going to be an explosion in the numbers of biosimilar products coming to market as patents expire. Consequently, in line with regulatory guidance, there will be a commensurate need to provide full characterisation of such biopharmaceuticals. The purpose of this article is to describe the array of the more common techniques used in biopharmaceutical characterisation (typically of protein or polypeptide). For full characterisation of a protein, the protein�s primary, secondary and tertiary structure as well as its physiochemical properties should be assessed.
More info >>


News and Press Releases

Are you keeping up to date with changes to pharmaceutical laws and guidance?

The legal and regulatory environment affecting the pharmaceutical industry is in a period of unprecedented change. Are you keeping up with all these changes?
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement